Ireland
--:--IST
Latest
Clinical Trials in Taiwan / NCT06596187
Recruiting Not applicable

Differential Assessment of Hypertonia

NCT06596187 · tracked via the Priya Life Science Taiwan tracker
Phase
Not applicable
Started
2024-10-09
Last updated
2024-10-15

Condition(s) studied

SCI - Spinal Cord InjuryPD - Parkinson's Disease

Investigational drug(s) / intervention(s)

Continuous passive motion device (CPM) of ankle - fastContinuous passive motion device (CPM) of ankle - slow

Continuous passive motion device (CPM) of ankle - fast: Continuous passive motion device (CPM) of ankle at 1HZ(60rpm) for 10 repetitions

Continuous passive motion device (CPM) of ankle - slow: Continuous passive motion device (CPM) of ankle 0.25HZ (15rpm) for 10 repetitions

Study summary

Spasticity and rigidity are common symptoms of central nervous system injuries, such as spinal cord injury and Parkinson's disease, and result in distinct patterns of increased resistance during passive joint movements. Spasticity is characterized by a velocity-dependent increase in stretch reflexes, accompanied by exaggerated tendon responses, while rigidity is marked by consistent resistance throughout the range of motion, traditionally considered independent of stretch velocity. However, recent studies suggest that rigidity may also be influenced by stretch velocity. This study aims to investigate muscle tone by examining spasticity, rigidity, and normal muscle function through neural and biomechanical changes. Standard clinical tools, such as the Modified Ashworth Scale and Unified Parkinson's Disease Rating Scale, along with additional assessments like the Myoton and Post-Activation Depression (PAD), will be employed.

Eligibility

Sex
ALL
Min age
20 Years
Max age
—
Healthy volunteers
Accepted
Health subjects: Exclusion Criteria: 1. Musculoskeletal injuries on legs. 2. Osteoporosis. SCI subjects: Inclusion Criteria 1. Participants with chronic spinal cord injury, with injury duration greater than one year. Exclusion Criteria 1. Current musculoskeletal or joint injuries in the lower limbs. 2. History of central or peripheral neuromuscular diseases. 3. Presence of a pacemaker. 4. Current use of antispastic or antidepressant medications. 5. Current venous thromboembolism or osteoporosis. 6. Impairment of the soleus H-reflex arc. PD subjects: Inclusion Criteria: \- Clinical diagnosis of Parkinson disease. Exclusion Criteria: 1. Musculoskeletal injuries on legs 2. Osteoporosis. 3. Any peripheral or central nervous system injury or disease patients.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Chang Gung University Taoyuan Taiwan Recruiting

More Chang Gung University trials in Taiwan

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06596187 on ClinicalTrials.gov ↗ ← All trials in Taiwan